Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	351.42	237.94	231.4	249.55	219.15
Short-Term Investments	1,520	1,176	1,167	384.44	1,130
Trading Asset Securities	14.46	-	5.57	49.6	-
Cash & Short-Term Investments	1,886	1,413	1,404	683.59	1,349
Cash Growth	33.46%	0.70%	105.34%	-49.34%	118.83%
Accounts Receivable	5,172	4,388	4,043	3,852	3,928
Other Receivables	90.54	88.82	134.02	57.8	119.38
Receivables	5,263	4,477	4,178	3,910	4,048
Inventory	1,507	1,257	1,184	1,031	1,239
Prepaid Expenses	41.7	24.7	27.76	24.21	31.9
Other Current Assets	765.17	1,066	1,315	1,325	1,100
Total Current Assets	9,463	8,238	8,109	6,974	7,769
Property, Plant & Equipment	4,567	4,177	3,694	3,729	2,948
Long-Term Investments	339.37	310.67	80.2	568.59	36.75
Goodwill	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	2.14	2.3	1.07	2.29	3.83
Long-Term Deferred Tax Assets	163.01	-	-	33.33	-
Other Long-Term Assets	311.87	207.29	154.99	184.42	252.93
Total Assets	14,924	13,013	12,116	11,569	11,087
Accounts Payable	1,042	714.18	609.65	863.9	926.06
Accrued Expenses	133.87	70.43	58.08	55.09	47.86
Short-Term Debt	27.53	228.92	324.17	460.14	607.03
Current Portion of Long-Term Debt	1.73	282.37	197.98	113.63	210.32
Current Portion of Leases	55.23	44.1	27.55	11.14	9.42
Current Income Taxes Payable	300.04	37.74	18.66	26.56	66.49
Current Unearned Revenue	61.78	45.7	69.24	34.7	90.08
Other Current Liabilities	733.16	298.21	268.73	367.44	373.6
Total Current Liabilities	2,355	1,722	1,574	1,933	2,331
Long-Term Debt	-	198.46	355.92	406.9	232.22
Long-Term Leases	133.01	127.19	92.79	27.17	34.92
Long-Term Unearned Revenue	0.2	0.47	0.61	0.74	0.87
Pension & Post-Retirement Benefits	20.66	33.63	26.74	26.89	10.74
Long-Term Deferred Tax Liabilities	-	3	35.93	-	13.23
Other Long-Term Liabilities	97.25	10.01	-	-	-
Total Liabilities	2,607	2,094	2,086	2,394	2,623
Common Stock	105.79	105.37	104.69	104.15	103.68
Additional Paid-In Capital	447.88	404.24	331.64	269.94	212.77
Retained Earnings	11,312	10,120	9,324	8,603	7,941
Comprehensive Income & Other	63.79	-126.06	-88.46	-138.53	-70.73
Total Common Equity	11,929	10,504	9,672	8,839	8,187
Minority Interest	388.6	414.71	357.9	335.27	277.6
Shareholders' Equity	12,318	10,918	10,030	9,174	8,465
Total Liabilities & Equity	14,924	13,013	12,116	11,569	11,087
Total Debt	217.5	881.04	998.4	1,019	1,094
Net Cash (Debt)	1,669	532.41	405.27	-335.39	255.5
Net Cash Growth	213.45%	31.37%	-	-	-
Net Cash Per Share	15.51	5.02	3.82	-3.18	2.43
Filing Date Shares Outstanding	105.79	105.37	104.69	104.15	103.68
Total Common Shares Outstanding	105.79	105.37	104.69	104.15	103.68
Working Capital	7,108	6,517	6,535	5,041	5,438
Book Value Per Share	112.76	99.68	92.39	84.87	78.97
Tangible Book Value	11,850	10,424	9,594	8,760	8,106
Tangible Book Value Per Share	112.01	98.93	91.64	84.10	78.19
Land	434.67	422.36	409.88	419.83	420.09
Buildings	1,465	1,360	1,369	1,437	1,059
Machinery	3,740	3,152	2,616	2,580	1,809
Construction In Progress	60.46	207.11	78.27	28.01	221.55